Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Telangana aims to make Hyderabad leading life sciences hub amid Centre’s Biopharma SHAKTI boost
Telangana is set to emerge as a major beneficiary of the Biopharma SHAKTI scheme, led by its well-established industry clusters, robust research ecosystem, and strong manufacturing capabilities. It already houses leading global pharmaceutical companies, such as Amgen, Zoetis, Evernorth, HCA Healthcare, Eli Lilly and Sanofi.
HealthCare Global Enterprises board approves ₹425-crore rights issue
The rights issue will be offered to equity shareholders as on a record date to be determined and notified by the company. Shares of Healthcare Global Enterprises Ltd ended at ₹578.60, down by ₹5.80, or 0.99%, on the BSE today, February 17.
Trade Spotlight: How should you trade Zydus Lifesciences, Laurus Labs, Global Health, Ather Energy, Info Edge India, and others on June 24?
The market is expected to consolidate with range-bound trading as long as it trades below the previous week's high. Below are some short-term trading ideas to consider.
Buy Park Medi World; target of Rs 350: Emkay Global Financial
Emkay Global Financial is bullish on Park Medi World has recommended buy rating on the stock with a target price of Rs 350 in its research report dated Jun 18, 2026.
Buy Star Health; target of Rs 650: Emkay Global Financial
Emkay Global Financial is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 650 in its research report dated April 29, 2026.
Stocks to Watch Today: Maruti Suzuki, Aster DM Health, IndiaMART, RailTel Corporation, ACC, Eveready Industries, Avenue Supermarts in focus on 4 May
Stocks to Watch, 04 Apr: Stocks like Adani Enterprises, Kotak Mahindra Bank, Avenue Supermarts, ACC, Sundram Fasteners, ESAF Small Finance Bank, Capri Global Capital, Eveready Industries India, RailTel Corporation of India, IndiaMART InterMESH, Sona BLW Precision Forgings, and Aster DM Healthcare will release their quarterly earnings on April 4.
Bank of Baroda shares fall over 4% after lender settles NMC Health litigation for Rs 5,700 crore
The settlement covers proceedings before the Abu Dhabi Global Market Court of First Instance and the High Court of Justice of England & Wales relating to the insolvency of the NMC entities
Buy HealthCare Global Enterprises; target of Rs 820: Prabhudas Lilladher
Prabhudas Lilladher is bullish on HealthCare Global Enterprises has recommended buy rating on the stock with a target price of Rs 820 in its research report dated May 21, 2026.
Trump Delays Iran Deal, Oil Jumps 2% | Wockhardt shares in focus on new drug approval | Opening Bell
Global markets remain on edge as Trump signals no rush for an Iran deal, oil prices climb above $93, and investors await RBI policy cues. FIIs continue selling while auto sales, Wockhardt, and geopolitical tensions stay in focus. Catch all the key triggers on Opening Bell.
Lupin targeting large specialty deals but with guardrails on debt and risk, says CFO Swaminathan
'We still don’t shy away from large acquisitions, but we are a lot more calibrated in our aggression, looking at protecting the downsides,” global CFO Ramesh Swaminathan tells Moneycontrol
Buy Ipca Laboratories; target of Rs 1800: Emkay Global Financial
Emkay Global Financial is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated June 02, 2026.
Buy Global Health; target of Rs 1400 Anand Rathi
Anand Rathi is bullish on Global Health recommended buy rating on the stock with a target price of Rs 1400 in its research report dated May 19, 2026.